Search Results - "Goemans N"

311P Development and pilot validation of the DuMAND checklist to screen for Duchenne muscular dystrophy-associated neurobehavioral difficulties (DuMAND).

Authors: Geuens, S. Goemans, N. Lemiere, J. et al.

Source: Neuromuscular Disorders. 2024 Supplement 1, Vol. 43, pN.PAG-N.PAG. 1p.

PCR28 Characterization of Patients with Duchenne Muscular Dystrophy across Previously Developed Health States.

Authors: Muntoni, F. Goemans, N. Posner, N. et al.

Source: Value in Health. 2023 Supplement, Vol. 26 Issue 6, pS316-S317. 2p.

P.65 Consistency of changes in percent-predicted forced vital capacity between real-world data and trial placebo arms in ambulatory Duchenne muscular dystrophy.

Authors: Goemans, N. McDonald, C. Muntoni, F. et al.

Source: Neuromuscular Disorders. 2022 Supplement 1, Vol. 32, pS68-S69. 2p.

DMD/BMD – OUTCOME MEASURES: EP.123 Functional trajectories of upper limb and pulmonary function before and after loss of ambulation in Duchenne muscular dystrophy.

Authors: Goemans, N. Signorovitch, J. McDonald, C. et al.

Source: Neuromuscular Disorders. 2021 Supplement 1, Vol. 31, pS86-S86. 1p.

Gait stage classification of children with Duchenne muscular dystrophy.

Authors: Vandekerckhove, I. Papageorgiou, E. Van den Hauwe, M. et al.

Source: Gait & Posture. 2021Supplement 1, Vol. 90, p291-292.

Longitudinal alterations of gait features in growing boys with Duchenne muscular dystrophy.

Authors: Vandekerckhove, I. Van den Hauwe, M. De Beukelaer, N. et al.

Source: Gait & Posture. 2020 Supplement 1, Vol. 81, p373-374.

PRO125 SUITABILITY OF NATURAL HISTORY DATA FOR EXTERNAL CONTROLS IN DUCHENNE MUSCULAR DYSTROPHY.

Authors: Goemans, N. Wong, B. Muntoni, F. et al.

Source: Value in Health. 2019 Supplement 3, Vol. 22, pS864-S864. 1p.

PRO126 A COMPOSITE PROGNOSTIC SCORE FOR TIME TO LOSS OF WALKING ABILITY IN DUCHENNE MUSCULAR DYSTROPHY (DMD).

Authors: Goemans, N. Signorovitch, J. Sajeev, G. et al.

Source: Value in Health. 2019 Supplement 3, Vol. 22, pS864-S864. 1p.

DUCHENNE MUSCULAR DYSTROPHY - PHYSIOTHERAPY: P.300Prognostic factors for changes in 4-stair climb ability in patients with Duchenne muscular dystrophy.

Authors: Goemans, N. Wong, B. Signorovitch, J. et al.

Source: Neuromuscular Disorders. Oct2018:Supplement 2, Vol. 28, pS121-S122. 1p.

REGISTRIES AND CARE OF NEUROMUSCULAR DISORDERS: P.284Quantifying activity changes of neuromuscular patients using the ACTIVLIM questionnaire: a 5-years longitudinal study.

Authors: Bleyenheuft, C. Goemans, N. Wanyama, S. et al.

Source: Neuromuscular Disorders. Oct2018:Supplement 2, Vol. 28, pS117-S117. 1p.

P 148 - Synergy complexity during maximal voluntary isometric contractions.

Authors: Goudriaan, M. Shuman, B.R. Steele, K.M. et al.

Source: Gait & Posture. Sep2018:Supplement 1, Vol. 65, p480-481.

P 003 - Gait deviations in children with Charcot-Marie Tooth's disease and their association with muscle weakness.

Authors: Callewaert, B. Goudriaan, M. den Hauwe, M. Van et al.

Source: Gait & Posture. Sep2018:Supplement 1, Vol. 65, p239-240.

G.P.115: Pooled analyses of efficacy parameters in patients with Duchenne muscular dystrophy (DMD): Results from the drisapersen (DRIS) clinical trial programme.

Authors: Goemans, N. Voit, T. McDonald, C.M. et al.

Source: Neuromuscular Disorders. Oct2014, Vol. 24 Issue 9/10, p829-830. 2p.

P.452 - Accelerating the translation of natural history into more effective clinical trial design through multi-stakeholder collaboration.

Authors: Mercuri, E. Goemans, N. Muntoni, F. et al.

Source: Neuromuscular Disorders. Oct2017 Supplement 2, Vol. 27, pS231-S232. 1p.

P.3 - Has outcome changed for adults with Duchenne muscular dystrophy?

Authors: Goemans, N. Dewaele, L. Claeys, K. et al.

Source: Neuromuscular Disorders. Oct2017 Supplement 2, Vol. 27, pS99-S100. 1p.

P.453 - Consistency between natural history and clinical trial placebo arms for 48-week changes in six-minute walk distance (6MWD) in patients with Duchenne muscular dystrophy (DMD).

Authors: Mercuri, E. Goemans, N. Sajeev, G. et al.

Source: Neuromuscular Disorders. Oct2017 Supplement 2, Vol. 27, pS232-S232. 1p.

P.454 - Validation of a prognostic score for changes in six-minute walk distance (6MWD) in patients with Duchenne muscular dystrophy (DMD).

Authors: Goemans, N. Hauwe, M. Vanden Sajeev, G. et al.

Source: Neuromuscular Disorders. Oct2017 Supplement 2, Vol. 27, pS232-S232. 1p.

P.2 - The association between muscle weakness and gait deviations in children with Duchenne muscular dystrophy.

Authors: Goudriaan, M. Goemans, N. Van Den Hauwe, M. et al.

Source: Neuromuscular Disorders. Oct2017 Supplement 2, Vol. 27, pS99-S99. 1p.

P.321 - Development of a prognostic model for 1-year change in 6-minute walk distance (6MWD) in patients with Duchenne muscular dystrophy (DMD).

Authors: Goemans, N. Signorovitch, J. Swallow, E. et al.

Source: Neuromuscular Disorders. Oct2016 Supplement 2, Vol. 26, pS182-S183. 1p.

P.370 - Toward an appropriate neuropsychological assessment protocol for children with myotonic dystrophy type 1.

Authors: Geuens, S. Goemans, N. Thiery, E. et al.

Source: Neuromuscular Disorders. Oct2016 Supplement 2, Vol. 26, pS196-S196. 1p.